Baxter Ralph 4
4 · Intapp, Inc. · Filed Dec 12, 2024
Insider Transaction Report
Form 4
Intapp, Inc.INTA
Baxter Ralph
Director
Transactions
- Exercise/Conversion
Common Stock
2024-12-10$3.99/sh+5,000$19,950→ 14,441 total - Sale
Common Stock
2024-12-11$70.03/sh−15,711$1,100,185→ 9,441 total - Sale
Common Stock
2024-12-10$67.74/sh−1,561$105,744→ 12,880 total - Exercise/Conversion
Common Stock
2024-12-11$3.99/sh+5,261$20,991→ 14,702 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-12-10−5,000→ 10,261 totalExercise: $3.99Exp: 2026-05-10→ Common Stock (5,000 underlying) - Sale
Common Stock
2024-12-10$68.42/sh−3,239$221,625→ 9,641 total - Sale
Common Stock
2024-12-10$69.23/sh−200$13,846→ 9,441 total - Exercise/Conversion
Common Stock
2024-12-11$7.45/sh+10,450$77,853→ 25,152 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-12-11−5,261→ 5,000 totalExercise: $3.99Exp: 2026-05-10→ Common Stock (5,261 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-12-11−10,450→ 115,550 totalExercise: $7.45Exp: 2027-05-22→ Common Stock (10,450 underlying)
Footnotes (3)
- [F1]The option exercise and sale of shares of common stock of Intapp, Inc. was executed pursuant to a 10b5-1 plan put in place by the Reporting Person on November 27, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from (a) with respect to the weighted average price of $67.7415: $67.09 to $67.98, inclusive, (b) with respect to the weighted average price of $68.424: $68.00 to $68.90, inclusive, (c) with respect to the weighted average price of $69.23: $69.21 to $69.25, inclusive, and (d) with respect to the weighted average price of $70.0264: $70.00 to $70.19, inclusive. The reporting person undertakes to provide to Intapp, Inc., any security holder of Intapp, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- [F3]The shares underlying this option are fully vested and exercisable as of the date hereof.